Kindred Biosciences, Inc. — Form D
Kindred Biosciences, Inc. of Burlingame, CA, a company, filed a Form D exempt-offering notice with the SEC on 2013-07-12. The offering totals $6.3M, of which $2.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-07-12
- Form: D
- Accession: 0001250853-13-000083
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $6.3M
- Amount sold: $2.6M
- Remaining: $3.8M
- Investors: 18
- Date of first sale: 2013-06-30
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-199586
Issuer
- Name: Kindred Biosciences, Inc.
- CIK: 0001561743
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 1499 Bayshore Hwy, #226, Burlingame, CA, 94010
- Phone: 650-701-7901
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Richard Chin | Director | San Francisco, CA |
| Richard Chin | Executive Officer | San Francisco, CA |
| Denise Bevers | Executive Officer | Norwood, MA |
| Ernest Mario | Director | Palo Alto, CA |
| Ervin Vezspremi | Director | Burlingame, CA |
| Stephen Sundlof | Executive Officer | Burlingame, CA |
Other filings by this issuer (3)
More